Have a question?
Contact us today!

PPD Neuroscience Research


Partnering to Achieve Your Next Neuroscience Breakthrough

We share your vision. Like you, the neuroscience team at PPD is driven to find answers in this area of drug development. With unmet needs outweighing treatment solutions for many conditions affecting the central nervous system (CNS), every step forward can have a monumental impact on how neurological disorders are managed—forever reshaping the future for patients and caregivers for the better. 

Armed with experience in novel treatment modalities and a broad range of indications, we can confidently guide you to your neuroscience breakthrough.

Preparing for Growth in Neurodegenerative Treatment Opportunities

Advances in the understanding of neurology and neurological diseases have led to significant progress in the development of treatments for neurodegenerative diseases. While patient enrollment and retention for clinical trials in this field can be challenging, CROs with the right expertise, tools and passion can help sponsors implement successful, cost-effective studies that minimize site and patient burden.

See how the innovative thinking of the PPD team makes it possible to bring breakthrough therapies for neurodegenerative diseases to market as quickly and cost-effectively as possible.

Access the Article

In the past five years, we have supported:

0 +

Neuroscience trials

0 +

Global patients

0 +

Global sites

Neuroscience Expertise Where You Need It

Our teams have neuroscience expertise from early development and Phase I, Phase IIb-III, peri- and post-approval, labs, and strategic regulatory and evidence strategy. Explore how we can support every phase of your clinical research development.

Expertise to Solve the Complexities of Neuroscience Research

With a proven ability to anticipate how patients, investigators, regulatory bodies, and payors respond to study drugs and the instincts to know when to pivot, we are poised to give you the intel needed to build the right strategy for your study.

neuroscience novel gene therapy icon
Novel gene therapies requiring direct CNS administration
neuroscience subjective assessments icon
Subjective assessments, management of inter-rater reliability, scale validation
neuroscience proven methods icon
Proven methods to get you to new drug application, marketing authorization application or biologics license application approval
neuroscience deployment of digital trial solutions icon
Deployment of digital trial solutions to reduce patient burden while increasing access to trials
neuroscience placebo response strategies icon
Placebo response strategies for more precise data outcomes
neuroscience incorporation of estimands icon
Incorporation of estimands into CNS study design, protocol development, and statistical strategy

Ingenuity for the Evolving Neuroscience Clinical Trial Landscape

We continue to invest in solutions and teams that improve neuroscience study certainty and quality for our clients and patients.

Clinical Trial Simulator

Works to identify potential gaps in the program early on and guide the selection of design parameters, used for indications such as Alzheimer’s and Parkinson’s disease.

Dedicated Patient Enrollment Solution

An expanding solution that links a robust patient database to both our traditional site network and our global wholly-owned network of sites.

Decentralized Clinical Trial Technology and Patient-Centric Solutions

Ease the burden on clinical trial participants and their caregivers with decentralized clinical trial (DCT) advancements, specifically for the neuroscience area of research.

These solutions include:

  • Telemedicine
  • Direct-to-patient models
  • Remote eConsent
  • eCOA/ePRO
  • Home health care services